Prevention and / or therapeutic medicinal composition of atopic dermatitis containing IL-31 antagonist as an active ingredient

摘要

To provide pharmaceutical compositions effective in the prevention and/or treatment of atopic dermatitis which can improve the QOL of patients.SOLUTION: A pharmaceutical composition for the prevention and/or treatment of atopic dermatitis containing IL-31 antagonist as an active ingredient is repeatedly administered at 0.1 mg to 1000 mg/body/2 weeks, 0.1 mg to 1000 mg/body/4 weeks, or 0.1 mg to 1000 mg/body/8 weeks to a subject suffering from or at risk for atopic dermatitis in an equivalence and a same administration interval.SELECTED DRAWING: None